NI
TAK icon

Natural Investments’s Takeda Pharmaceutical TAK Stock Holding History

Natural Investments’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$276K Buy
17,230
+596
+4% +$9.86K 0.06% 242
2026
Q1 		$308K Buy
16,634
+110
+0.7% +$1.93K 0.08% 217
2025
Q4 		$257K Buy
16,524
+3,344
+25% +$47.8K 0.06% 237
2025
Q3 		$192K Buy
13,180
+617
+5% +$9.16K 0.05% 230
2025
Q2 		$194K Buy
+12,563
New +$186K 0.05% 245

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Natural Investments's TAK Position: Q2 2026 in Review

Natural Investments increased its Takeda Pharmaceutical (TAK) stake by 3.6% in Q2 2026, buying an estimated $9.86K and bringing the position to 17,230 shares worth $276K. The position accounts for 0.06% of the portfolio, ranked #242.

Natural Investments first reported a position in TAK in Q2 2025 and has held it in 5 quarters since. The position peaked at $308K in Q1 2026. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Natural Investments held 17,230 shares of Takeda Pharmaceutical worth $276K as of Q2 2026.
  • Natural Investments bought 596 Takeda Pharmaceutical shares in Q2 2026, an estimated $9.86K.
  • Takeda Pharmaceutical made up 0.06% of Natural Investments's portfolio in Q2 2026, its #242 holding.
  • Natural Investments first reported a position in Takeda Pharmaceutical in Q2 2025 and has held it in 5 quarters since.
  • Natural Investments's Takeda Pharmaceutical position peaked at $308K in Q1 2026.
  • 376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Natural Investments's 13F filing for Q2 2026, filed 31 Jul 2026.